Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebral Hemorrhage | 95 | 2023 | 2647 | 10.170 |
Why?
|
Stroke | 96 | 2023 | 9981 | 5.130 |
Why?
|
Brain Edema | 11 | 2023 | 617 | 3.160 |
Why?
|
Brain Ischemia | 31 | 2023 | 3265 | 2.800 |
Why?
|
Deferoxamine | 10 | 2022 | 151 | 2.480 |
Why?
|
Hematoma | 16 | 2023 | 758 | 2.240 |
Why?
|
Tissue Plasminogen Activator | 19 | 2020 | 1261 | 2.190 |
Why?
|
Thrombolytic Therapy | 17 | 2023 | 2162 | 2.150 |
Why?
|
Intracranial Hemorrhages | 11 | 2023 | 855 | 1.830 |
Why?
|
Fibrinolytic Agents | 16 | 2022 | 2158 | 1.810 |
Why?
|
Cerebral Infarction | 9 | 2021 | 1011 | 1.560 |
Why?
|
Anticoagulants | 15 | 2019 | 4600 | 1.300 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 12 | 2023 | 3255 | 1.290 |
Why?
|
Iron Chelating Agents | 2 | 2019 | 139 | 1.250 |
Why?
|
Thrombectomy | 7 | 2023 | 680 | 1.030 |
Why?
|
Cerebrovascular Circulation | 11 | 2021 | 2732 | 1.030 |
Why?
|
Cerebral Angiography | 9 | 2023 | 1285 | 0.980 |
Why?
|
Intracranial Thrombosis | 3 | 2013 | 113 | 0.910 |
Why?
|
Cerebral Amyloid Angiopathy | 7 | 2023 | 859 | 0.880 |
Why?
|
Edema | 3 | 2023 | 789 | 0.860 |
Why?
|
Vertebrobasilar Insufficiency | 2 | 2021 | 114 | 0.810 |
Why?
|
Middle Cerebral Artery | 4 | 2013 | 264 | 0.790 |
Why?
|
Siderophores | 2 | 2013 | 57 | 0.780 |
Why?
|
Randomized Controlled Trials as Topic | 14 | 2023 | 9955 | 0.740 |
Why?
|
Perfusion Imaging | 2 | 2019 | 195 | 0.650 |
Why?
|
Humans | 207 | 2023 | 744366 | 0.640 |
Why?
|
Antihypertensive Agents | 5 | 2017 | 2047 | 0.620 |
Why?
|
Aged | 98 | 2023 | 163288 | 0.610 |
Why?
|
Factor V | 1 | 2018 | 178 | 0.590 |
Why?
|
Aged, 80 and over | 58 | 2021 | 57776 | 0.590 |
Why?
|
Hyperlipidemias | 1 | 2022 | 789 | 0.590 |
Why?
|
Iron | 6 | 2019 | 1774 | 0.580 |
Why?
|
Microvessels | 3 | 2017 | 544 | 0.570 |
Why?
|
Oxidative Stress | 2 | 2022 | 3084 | 0.570 |
Why?
|
Off-Label Use | 2 | 2017 | 169 | 0.560 |
Why?
|
Arterial Occlusive Diseases | 3 | 2019 | 793 | 0.550 |
Why?
|
Diffusion Magnetic Resonance Imaging | 6 | 2021 | 2737 | 0.550 |
Why?
|
Carotid Stenosis | 4 | 2017 | 854 | 0.550 |
Why?
|
Neuroprotective Agents | 5 | 2022 | 941 | 0.540 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2020 | 1184 | 0.540 |
Why?
|
Subarachnoid Space | 1 | 2015 | 79 | 0.540 |
Why?
|
Leukoaraiosis | 3 | 2012 | 120 | 0.520 |
Why?
|
Endovascular Procedures | 5 | 2017 | 1980 | 0.510 |
Why?
|
Ischemic Preconditioning | 1 | 2015 | 92 | 0.500 |
Why?
|
Severity of Illness Index | 15 | 2019 | 15535 | 0.490 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2014 | 3070 | 0.490 |
Why?
|
Nervous System Diseases | 4 | 2022 | 1622 | 0.480 |
Why?
|
Middle Aged | 88 | 2022 | 213390 | 0.470 |
Why?
|
Nomograms | 1 | 2015 | 228 | 0.460 |
Why?
|
Comprehensive Health Care | 1 | 2014 | 127 | 0.460 |
Why?
|
Female | 112 | 2023 | 380193 | 0.460 |
Why?
|
Hematoma, Epidural, Cranial | 2 | 2013 | 60 | 0.460 |
Why?
|
Atrial Fibrillation | 5 | 2017 | 5035 | 0.460 |
Why?
|
Male | 114 | 2023 | 350115 | 0.460 |
Why?
|
Blood Pressure | 7 | 2017 | 8551 | 0.440 |
Why?
|
Pyramidal Tracts | 1 | 2014 | 256 | 0.430 |
Why?
|
Patient Transfer | 3 | 2018 | 762 | 0.420 |
Why?
|
Tangier Disease | 1 | 2011 | 11 | 0.420 |
Why?
|
Magnetic Resonance Imaging | 30 | 2023 | 35425 | 0.410 |
Why?
|
Arm | 1 | 2015 | 589 | 0.410 |
Why?
|
Survivors | 1 | 2022 | 2291 | 0.410 |
Why?
|
Circadian Rhythm | 6 | 2021 | 2624 | 0.400 |
Why?
|
Hypertension | 8 | 2023 | 8479 | 0.400 |
Why?
|
Ischemic Attack, Transient | 6 | 2020 | 935 | 0.390 |
Why?
|
Retrospective Studies | 44 | 2023 | 77460 | 0.380 |
Why?
|
Treatment Outcome | 29 | 2023 | 63107 | 0.380 |
Why?
|
Arteriovenous Malformations | 1 | 2014 | 396 | 0.380 |
Why?
|
Carotid Artery, Internal | 1 | 2013 | 445 | 0.380 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2006 | 1516 | 0.370 |
Why?
|
Decompressive Craniectomy | 1 | 2011 | 72 | 0.360 |
Why?
|
Infarction, Middle Cerebral Artery | 7 | 2023 | 475 | 0.360 |
Why?
|
Critical Care | 2 | 2013 | 2647 | 0.350 |
Why?
|
Hemostatics | 1 | 2012 | 229 | 0.350 |
Why?
|
Hemostasis | 1 | 2012 | 458 | 0.350 |
Why?
|
Deglutition Disorders | 4 | 2022 | 606 | 0.340 |
Why?
|
Apolipoprotein E2 | 4 | 2014 | 127 | 0.340 |
Why?
|
Tomography, X-Ray Computed | 20 | 2023 | 20130 | 0.330 |
Why?
|
Risk Factors | 31 | 2022 | 72296 | 0.330 |
Why?
|
Brain | 21 | 2023 | 26388 | 0.330 |
Why?
|
Globus Pallidus | 2 | 2009 | 253 | 0.320 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2013 | 500 | 0.320 |
Why?
|
Subarachnoid Hemorrhage | 4 | 2021 | 1018 | 0.320 |
Why?
|
Anesthesia, Local | 1 | 2010 | 275 | 0.320 |
Why?
|
Hippocampus | 1 | 2021 | 3675 | 0.320 |
Why?
|
Cerebral Arterial Diseases | 2 | 2019 | 82 | 0.310 |
Why?
|
Magnetic Resonance Angiography | 4 | 2011 | 1443 | 0.310 |
Why?
|
Diffusion Tensor Imaging | 2 | 2015 | 2305 | 0.310 |
Why?
|
Movement Disorders | 1 | 2011 | 446 | 0.300 |
Why?
|
Carotid Artery Diseases | 1 | 2013 | 879 | 0.290 |
Why?
|
Time Factors | 20 | 2021 | 40075 | 0.290 |
Why?
|
Genetic Predisposition to Disease | 12 | 2020 | 17446 | 0.290 |
Why?
|
Endocarditis | 1 | 2011 | 349 | 0.290 |
Why?
|
Warfarin | 6 | 2018 | 1497 | 0.290 |
Why?
|
Epidermal Growth Factor | 2 | 2019 | 709 | 0.280 |
Why?
|
Cerebral Veins | 1 | 2008 | 156 | 0.280 |
Why?
|
Recovery of Function | 4 | 2014 | 2926 | 0.280 |
Why?
|
Endarterectomy, Carotid | 2 | 2011 | 546 | 0.280 |
Why?
|
Brain Injuries | 3 | 2023 | 2029 | 0.280 |
Why?
|
Acute Disease | 6 | 2020 | 7147 | 0.270 |
Why?
|
Dizziness | 2 | 2022 | 251 | 0.270 |
Why?
|
Angioplasty | 1 | 2008 | 364 | 0.270 |
Why?
|
Venous Thrombosis | 2 | 2013 | 1239 | 0.270 |
Why?
|
Prognosis | 17 | 2023 | 29060 | 0.260 |
Why?
|
Spinal Puncture | 2 | 2017 | 281 | 0.260 |
Why?
|
Odds Ratio | 7 | 2023 | 9849 | 0.260 |
Why?
|
Software | 1 | 2019 | 4441 | 0.260 |
Why?
|
Ferritins | 1 | 2008 | 590 | 0.260 |
Why?
|
Gastrostomy | 2 | 2022 | 310 | 0.250 |
Why?
|
Infusions, Intravenous | 4 | 2019 | 2274 | 0.250 |
Why?
|
Aspirin | 2 | 2014 | 3283 | 0.250 |
Why?
|
Needles | 2 | 2017 | 449 | 0.240 |
Why?
|
Cohort Studies | 20 | 2023 | 40559 | 0.240 |
Why?
|
Predictive Value of Tests | 14 | 2021 | 15078 | 0.240 |
Why?
|
Polymorphism, Single Nucleotide | 10 | 2020 | 15520 | 0.240 |
Why?
|
Vasculitis | 1 | 2008 | 519 | 0.230 |
Why?
|
Antioxidants | 1 | 2012 | 1659 | 0.230 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 957 | 0.230 |
Why?
|
Risk Assessment | 13 | 2021 | 23336 | 0.230 |
Why?
|
Brain Infarction | 2 | 2020 | 299 | 0.230 |
Why?
|
Research Design | 2 | 2023 | 5984 | 0.230 |
Why?
|
Anesthesia, General | 1 | 2010 | 1171 | 0.220 |
Why?
|
Hypolipidemic Agents | 2 | 2022 | 604 | 0.220 |
Why?
|
Evidence-Based Medicine | 3 | 2012 | 3611 | 0.220 |
Why?
|
Creatinine | 1 | 2008 | 1919 | 0.220 |
Why?
|
Vitamin K | 3 | 2019 | 295 | 0.220 |
Why?
|
Blood Coagulation Factors | 2 | 2017 | 355 | 0.220 |
Why?
|
Apolipoproteins E | 4 | 2019 | 1438 | 0.220 |
Why?
|
Genetic Variation | 7 | 2015 | 6542 | 0.210 |
Why?
|
Hemorrhage | 2 | 2012 | 3461 | 0.210 |
Why?
|
Activities of Daily Living | 3 | 2012 | 2419 | 0.210 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2022 | 45 | 0.210 |
Why?
|
Vertebral Artery Dissection | 1 | 2022 | 48 | 0.210 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2005 | 641 | 0.210 |
Why?
|
Aquaporins | 1 | 2022 | 174 | 0.200 |
Why?
|
Prospective Studies | 19 | 2023 | 53290 | 0.200 |
Why?
|
Medical Futility | 2 | 2022 | 127 | 0.200 |
Why?
|
Spinocerebellar Degenerations | 1 | 2001 | 43 | 0.200 |
Why?
|
Fibrinolysis | 1 | 2022 | 322 | 0.190 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2001 | 101 | 0.190 |
Why?
|
Vertigo | 1 | 2022 | 202 | 0.190 |
Why?
|
American Heart Association | 4 | 2023 | 1057 | 0.190 |
Why?
|
Health Services Needs and Demand | 1 | 2008 | 1410 | 0.190 |
Why?
|
Automation | 2 | 2021 | 584 | 0.180 |
Why?
|
Injections, Intraventricular | 2 | 2017 | 231 | 0.180 |
Why?
|
Health Care Costs | 1 | 2013 | 3208 | 0.180 |
Why?
|
Thromboembolism | 1 | 2006 | 987 | 0.180 |
Why?
|
Hematoma, Subdural, Chronic | 1 | 2021 | 90 | 0.180 |
Why?
|
Neural Stem Cells | 2 | 2019 | 851 | 0.180 |
Why?
|
Hydrogels | 3 | 2019 | 724 | 0.180 |
Why?
|
Double-Blind Method | 5 | 2022 | 12025 | 0.170 |
Why?
|
Ataxia | 1 | 2001 | 304 | 0.170 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2022 | 478 | 0.170 |
Why?
|
Decision Making | 1 | 2013 | 3888 | 0.170 |
Why?
|
Radiography | 5 | 2022 | 7023 | 0.170 |
Why?
|
Seizures | 2 | 2021 | 2859 | 0.170 |
Why?
|
Embolism | 1 | 2022 | 408 | 0.170 |
Why?
|
Hemifacial Spasm | 1 | 2018 | 23 | 0.160 |
Why?
|
Blood Flow Velocity | 4 | 2012 | 1423 | 0.160 |
Why?
|
Respiration Disorders | 1 | 2022 | 371 | 0.160 |
Why?
|
Random Allocation | 3 | 2023 | 2428 | 0.160 |
Why?
|
Cerebrum | 2 | 2010 | 137 | 0.160 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 629 | 0.160 |
Why?
|
Genome-Wide Association Study | 10 | 2020 | 12262 | 0.160 |
Why?
|
Contrast Media | 3 | 2022 | 5300 | 0.150 |
Why?
|
Echo-Planar Imaging | 1 | 2002 | 659 | 0.150 |
Why?
|
Body Weight | 1 | 2008 | 4671 | 0.150 |
Why?
|
ROC Curve | 7 | 2021 | 3528 | 0.150 |
Why?
|
Caspase 3 | 1 | 2020 | 758 | 0.150 |
Why?
|
Amyloid beta-Peptides | 2 | 2022 | 3587 | 0.150 |
Why?
|
Kidney Diseases | 1 | 2008 | 2148 | 0.150 |
Why?
|
Genetic Association Studies | 3 | 2018 | 2703 | 0.150 |
Why?
|
Postoperative Complications | 3 | 2011 | 15297 | 0.150 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2018 | 437 | 0.140 |
Why?
|
Post-Dural Puncture Headache | 1 | 2017 | 49 | 0.140 |
Why?
|
Facial Nerve | 1 | 2018 | 271 | 0.140 |
Why?
|
Anticholesteremic Agents | 1 | 2023 | 979 | 0.140 |
Why?
|
Hospital Mortality | 3 | 2018 | 5316 | 0.130 |
Why?
|
Epilepsy | 2 | 2021 | 3310 | 0.130 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2016 | 110 | 0.130 |
Why?
|
Linear Models | 5 | 2022 | 5953 | 0.130 |
Why?
|
Secondary Prevention | 1 | 2022 | 1530 | 0.130 |
Why?
|
Hydrocephalus | 1 | 2022 | 748 | 0.130 |
Why?
|
Adult | 31 | 2021 | 214052 | 0.130 |
Why?
|
Central Nervous System Depressants | 1 | 1996 | 167 | 0.130 |
Why?
|
Histone Deacetylases | 1 | 2020 | 728 | 0.130 |
Why?
|
Neuroradiography | 1 | 2015 | 70 | 0.130 |
Why?
|
Hyperglycemia | 1 | 2023 | 1373 | 0.120 |
Why?
|
Receptors, Lysosphingolipid | 1 | 2015 | 122 | 0.120 |
Why?
|
Cholesterol, LDL | 2 | 2023 | 2355 | 0.120 |
Why?
|
Risk | 6 | 2016 | 9688 | 0.120 |
Why?
|
Serotonin | 2 | 1996 | 1017 | 0.120 |
Why?
|
Collagen Type IV | 1 | 2015 | 140 | 0.120 |
Why?
|
Blood Coagulation Disorders | 1 | 2017 | 337 | 0.120 |
Why?
|
Internationality | 1 | 2019 | 1002 | 0.120 |
Why?
|
Reproducibility of Results | 7 | 2021 | 19905 | 0.120 |
Why?
|
Infarction, Posterior Cerebral Artery | 1 | 2013 | 14 | 0.120 |
Why?
|
Glutamic Acid | 3 | 1996 | 1169 | 0.120 |
Why?
|
Case-Control Studies | 9 | 2020 | 21748 | 0.120 |
Why?
|
Heme Oxygenase-1 | 1 | 2016 | 381 | 0.120 |
Why?
|
Respiration, Artificial | 2 | 2018 | 2569 | 0.120 |
Why?
|
Comorbidity | 3 | 2018 | 10388 | 0.120 |
Why?
|
Administration, Oral | 5 | 2019 | 3914 | 0.120 |
Why?
|
Calcinosis | 1 | 2022 | 1499 | 0.110 |
Why?
|
Nucleus Accumbens | 1 | 1996 | 366 | 0.110 |
Why?
|
Cardiac Surgical Procedures | 1 | 2008 | 3537 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2021 | 8949 | 0.110 |
Why?
|
Ducks | 1 | 2012 | 12 | 0.110 |
Why?
|
Injections, Intravenous | 2 | 2014 | 1420 | 0.110 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2008 | 333 | 0.110 |
Why?
|
Intracranial Hemorrhage, Hypertensive | 1 | 2012 | 20 | 0.110 |
Why?
|
Patient Selection | 3 | 2021 | 4216 | 0.110 |
Why?
|
International Normalized Ratio | 2 | 2012 | 367 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5749 | 0.110 |
Why?
|
Glioma | 1 | 2007 | 3401 | 0.110 |
Why?
|
Sneddon Syndrome | 1 | 2011 | 1 | 0.110 |
Why?
|
Collagen | 1 | 2021 | 2688 | 0.110 |
Why?
|
Vasospasm, Intracranial | 1 | 2014 | 208 | 0.110 |
Why?
|
China | 1 | 2018 | 2245 | 0.100 |
Why?
|
Data Interpretation, Statistical | 2 | 2020 | 2716 | 0.100 |
Why?
|
Genotype | 10 | 2018 | 12952 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1888 | 0.100 |
Why?
|
United States | 13 | 2023 | 69872 | 0.100 |
Why?
|
Astrocytes | 1 | 2019 | 1273 | 0.100 |
Why?
|
Receptors, Complement 3b | 1 | 2012 | 145 | 0.100 |
Why?
|
Prevalence | 4 | 2019 | 15221 | 0.100 |
Why?
|
Capillary Permeability | 1 | 2015 | 798 | 0.100 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2014 | 658 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2021 | 1916 | 0.100 |
Why?
|
Cerebrospinal Fluid | 1 | 2014 | 535 | 0.100 |
Why?
|
Cerebral Ventricles | 1 | 2014 | 544 | 0.100 |
Why?
|
Anisotropy | 1 | 2014 | 1265 | 0.100 |
Why?
|
Deglutition | 1 | 2012 | 198 | 0.100 |
Why?
|
Age of Onset | 1 | 2018 | 3270 | 0.100 |
Why?
|
Corpus Callosum | 1 | 2015 | 737 | 0.100 |
Why?
|
Lipids | 1 | 2022 | 3307 | 0.100 |
Why?
|
Databases, Factual | 2 | 2023 | 7730 | 0.090 |
Why?
|
Oxidative Phosphorylation | 1 | 2013 | 481 | 0.090 |
Why?
|
Body Mass Index | 1 | 2008 | 12721 | 0.090 |
Why?
|
Biocompatible Materials | 1 | 2019 | 1736 | 0.090 |
Why?
|
Demography | 3 | 2005 | 1655 | 0.090 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2010 | 292 | 0.090 |
Why?
|
Intubation | 1 | 2010 | 141 | 0.090 |
Why?
|
Peripheral Nervous System | 1 | 2011 | 150 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8385 | 0.090 |
Why?
|
Disease Models, Animal | 7 | 2021 | 18034 | 0.090 |
Why?
|
Boston | 3 | 2018 | 9312 | 0.090 |
Why?
|
Intubation, Intratracheal | 1 | 2018 | 1364 | 0.090 |
Why?
|
Tilt-Table Test | 1 | 2009 | 78 | 0.090 |
Why?
|
Constriction, Pathologic | 1 | 2013 | 1107 | 0.090 |
Why?
|
Ethanol | 1 | 1996 | 1342 | 0.090 |
Why?
|
Models, Economic | 1 | 2013 | 712 | 0.090 |
Why?
|
Dementia | 1 | 2023 | 2518 | 0.090 |
Why?
|
Long QT Syndrome | 1 | 2013 | 453 | 0.080 |
Why?
|
Placebos | 1 | 2013 | 1676 | 0.080 |
Why?
|
Platelet Function Tests | 1 | 2010 | 270 | 0.080 |
Why?
|
Genes | 1 | 2013 | 1893 | 0.080 |
Why?
|
Temporal Lobe | 2 | 2013 | 1670 | 0.080 |
Why?
|
Dipyridamole | 1 | 2008 | 145 | 0.080 |
Why?
|
Equipment Design | 1 | 2017 | 3582 | 0.080 |
Why?
|
Stents | 3 | 2017 | 3282 | 0.080 |
Why?
|
Emergency Medical Services | 2 | 2020 | 1917 | 0.080 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2011 | 560 | 0.080 |
Why?
|
Observer Variation | 3 | 2021 | 2593 | 0.080 |
Why?
|
Cost Savings | 1 | 2013 | 925 | 0.080 |
Why?
|
Animals | 17 | 2022 | 168768 | 0.080 |
Why?
|
Multicenter Studies as Topic | 2 | 2023 | 1677 | 0.080 |
Why?
|
Emergency Service, Hospital | 4 | 2022 | 7658 | 0.080 |
Why?
|
Recurrence | 2 | 2011 | 8340 | 0.080 |
Why?
|
Sepsis | 1 | 2022 | 2593 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2219 | 0.080 |
Why?
|
Homeostasis | 2 | 2012 | 3339 | 0.080 |
Why?
|
Sex Factors | 3 | 2013 | 10400 | 0.080 |
Why?
|
Follow-Up Studies | 7 | 2018 | 39052 | 0.080 |
Why?
|
Neurologic Examination | 1 | 2011 | 931 | 0.080 |
Why?
|
Logistic Models | 5 | 2023 | 13409 | 0.080 |
Why?
|
Dementia, Vascular | 1 | 2008 | 129 | 0.070 |
Why?
|
Rats, Wistar | 2 | 2022 | 1892 | 0.070 |
Why?
|
Disease Progression | 3 | 2019 | 13286 | 0.070 |
Why?
|
Hospital Costs | 1 | 2013 | 985 | 0.070 |
Why?
|
Drug Therapy, Combination | 2 | 2008 | 6489 | 0.070 |
Why?
|
Foramen Ovale, Patent | 1 | 2010 | 223 | 0.070 |
Why?
|
Behavioral Symptoms | 1 | 2009 | 175 | 0.070 |
Why?
|
Diagnosis, Differential | 6 | 2016 | 12961 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 2 | 2022 | 4042 | 0.070 |
Why?
|
Age Factors | 3 | 2013 | 18373 | 0.070 |
Why?
|
Substantia Nigra | 1 | 2008 | 353 | 0.070 |
Why?
|
Neovascularization, Physiologic | 1 | 2014 | 1351 | 0.070 |
Why?
|
Phlebography | 1 | 2008 | 333 | 0.070 |
Why?
|
Apolipoprotein E4 | 1 | 2010 | 668 | 0.070 |
Why?
|
Statistics, Nonparametric | 2 | 2018 | 2887 | 0.070 |
Why?
|
Angioplasty, Balloon | 1 | 2010 | 653 | 0.070 |
Why?
|
Kidney Function Tests | 1 | 2008 | 683 | 0.070 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2022 | 638 | 0.070 |
Why?
|
Brain Neoplasms | 1 | 2007 | 8861 | 0.070 |
Why?
|
Reperfusion | 2 | 2023 | 284 | 0.070 |
Why?
|
Obesity | 1 | 2008 | 12746 | 0.070 |
Why?
|
Vasoconstriction | 1 | 2009 | 597 | 0.070 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 1584 | 0.070 |
Why?
|
Aphasia | 1 | 2007 | 184 | 0.070 |
Why?
|
Drug Costs | 1 | 2013 | 1105 | 0.070 |
Why?
|
Sexual Behavior | 1 | 2015 | 2055 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2012 | 1405 | 0.070 |
Why?
|
Prefrontal Cortex | 1 | 1996 | 2147 | 0.070 |
Why?
|
Vascular Resistance | 1 | 2008 | 936 | 0.070 |
Why?
|
Posture | 1 | 2010 | 958 | 0.070 |
Why?
|
Hypercholesterolemia | 1 | 2012 | 1151 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3318 | 0.060 |
Why?
|
Hypotension | 1 | 2011 | 884 | 0.060 |
Why?
|
Postural Balance | 1 | 2010 | 620 | 0.060 |
Why?
|
Physicians | 1 | 2023 | 4567 | 0.060 |
Why?
|
Electric Stimulation Therapy | 1 | 2011 | 605 | 0.060 |
Why?
|
Delayed-Action Preparations | 1 | 2008 | 968 | 0.060 |
Why?
|
Cerebral Cortex | 3 | 2011 | 5709 | 0.060 |
Why?
|
Clinical Trials as Topic | 3 | 2021 | 7914 | 0.060 |
Why?
|
Functional Laterality | 2 | 2010 | 2290 | 0.060 |
Why?
|
Syndrome | 1 | 2011 | 3252 | 0.060 |
Why?
|
Pneumonia | 1 | 2016 | 2133 | 0.060 |
Why?
|
Rats | 6 | 2022 | 24252 | 0.060 |
Why?
|
Disability Evaluation | 2 | 2010 | 1828 | 0.060 |
Why?
|
Vasodilation | 1 | 2009 | 944 | 0.060 |
Why?
|
Alleles | 2 | 2013 | 6933 | 0.060 |
Why?
|
Endothelial Cells | 2 | 2015 | 3486 | 0.060 |
Why?
|
Enteral Nutrition | 1 | 2010 | 767 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2008 | 11726 | 0.060 |
Why?
|
Ischemia | 2 | 2023 | 1907 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2010 | 868 | 0.060 |
Why?
|
Nerve Degeneration | 1 | 2008 | 748 | 0.060 |
Why?
|
Blood Glucose | 1 | 2018 | 6254 | 0.060 |
Why?
|
Cognition Disorders | 2 | 2016 | 4043 | 0.060 |
Why?
|
Diffusion | 2 | 2002 | 832 | 0.060 |
Why?
|
Incidence | 2 | 2020 | 20952 | 0.060 |
Why?
|
Alberta | 1 | 2023 | 64 | 0.060 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4933 | 0.060 |
Why?
|
Extracellular Space | 2 | 1996 | 595 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2008 | 1851 | 0.060 |
Why?
|
Evans Blue | 1 | 2022 | 45 | 0.060 |
Why?
|
Ticlopidine | 1 | 2008 | 899 | 0.050 |
Why?
|
Perfusion | 1 | 2007 | 1360 | 0.050 |
Why?
|
Carotid Artery Thrombosis | 1 | 2002 | 53 | 0.050 |
Why?
|
Musculoskeletal Diseases | 1 | 2009 | 581 | 0.050 |
Why?
|
Phenotype | 2 | 2018 | 16367 | 0.050 |
Why?
|
Multivariate Analysis | 4 | 2016 | 12244 | 0.050 |
Why?
|
Hemoglobins | 1 | 2008 | 1532 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2023 | 780 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2012 | 2585 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
Chronic Disease | 3 | 2015 | 9145 | 0.050 |
Why?
|
Hospitals | 1 | 2016 | 3954 | 0.050 |
Why?
|
Metabolic Diseases | 1 | 2009 | 658 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
Cholesterol, HDL | 2 | 2020 | 1813 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11718 | 0.050 |
Why?
|
Health Personnel | 1 | 2015 | 3219 | 0.050 |
Why?
|
Microdialysis | 3 | 1996 | 158 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 4 | 2021 | 8300 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5388 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10259 | 0.050 |
Why?
|
Embolization, Therapeutic | 1 | 2010 | 1392 | 0.050 |
Why?
|
Glomerular Filtration Rate | 1 | 2008 | 2166 | 0.050 |
Why?
|
Models, Statistical | 1 | 2015 | 5101 | 0.050 |
Why?
|
Cells, Cultured | 4 | 2019 | 19233 | 0.050 |
Why?
|
Gastrointestinal Diseases | 1 | 2009 | 1170 | 0.050 |
Why?
|
Glasgow Coma Scale | 1 | 2022 | 570 | 0.050 |
Why?
|
Vascular Diseases | 1 | 2009 | 1161 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2008 | 3480 | 0.050 |
Why?
|
Eligibility Determination | 1 | 2023 | 403 | 0.040 |
Why?
|
Albumins | 1 | 2022 | 568 | 0.040 |
Why?
|
Diagnostic Imaging | 2 | 2011 | 3508 | 0.040 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2021 | 529 | 0.040 |
Why?
|
Psychotropic Drugs | 1 | 2005 | 894 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1782 | 0.040 |
Why?
|
Water | 2 | 2002 | 1395 | 0.040 |
Why?
|
Troponin | 1 | 2022 | 524 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2020 | 25039 | 0.040 |
Why?
|
Gelatin | 1 | 2019 | 225 | 0.040 |
Why?
|
Migraine Disorders | 1 | 2010 | 1620 | 0.040 |
Why?
|
Disease Management | 2 | 2021 | 2460 | 0.040 |
Why?
|
Collateral Circulation | 1 | 2018 | 287 | 0.040 |
Why?
|
Hemodynamics | 1 | 2007 | 4196 | 0.040 |
Why?
|
Coronary Artery Bypass | 1 | 2007 | 2288 | 0.040 |
Why?
|
Suprachiasmatic Nucleus | 2 | 1995 | 148 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1119 | 0.040 |
Why?
|
Minnesota | 1 | 2017 | 344 | 0.040 |
Why?
|
Hearing Disorders | 1 | 2017 | 124 | 0.040 |
Why?
|
Coma | 1 | 2000 | 475 | 0.040 |
Why?
|
Vitamins | 1 | 2005 | 1623 | 0.040 |
Why?
|
Drainage | 1 | 2022 | 1142 | 0.030 |
Why?
|
Atrophy | 2 | 2012 | 1584 | 0.030 |
Why?
|
Registries | 4 | 2021 | 8091 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2022 | 1019 | 0.030 |
Why?
|
Pilot Projects | 3 | 2014 | 8319 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 1 | 2022 | 1133 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2009 | 3326 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 1996 | 425 | 0.030 |
Why?
|
Heart Diseases | 1 | 2008 | 2789 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2007 | 4576 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7282 | 0.030 |
Why?
|
Pressure | 1 | 2018 | 1203 | 0.030 |
Why?
|
Wakefulness | 1 | 2002 | 1245 | 0.030 |
Why?
|
Rats, Inbred F344 | 1 | 1996 | 862 | 0.030 |
Why?
|
History, 21st Century | 1 | 2021 | 1534 | 0.030 |
Why?
|
Ceruloplasmin | 1 | 2014 | 56 | 0.030 |
Why?
|
Young Adult | 3 | 2020 | 56429 | 0.030 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2018 | 274 | 0.030 |
Why?
|
Maze Learning | 1 | 2016 | 478 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 1996 | 1162 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2015 | 513 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 2960 | 0.030 |
Why?
|
NF-kappa B | 1 | 2022 | 2499 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8664 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2016 | 21833 | 0.030 |
Why?
|
History, 20th Century | 1 | 2021 | 2740 | 0.030 |
Why?
|
Back Pain | 1 | 2017 | 545 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2016 | 601 | 0.030 |
Why?
|
Tryptophan | 1 | 1995 | 478 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7182 | 0.030 |
Why?
|
tau Proteins | 1 | 2022 | 1868 | 0.030 |
Why?
|
Triglycerides | 1 | 2020 | 2453 | 0.030 |
Why?
|
Electroencephalography | 1 | 2007 | 6151 | 0.030 |
Why?
|
Receptors, GABA-A | 1 | 1996 | 627 | 0.030 |
Why?
|
Species Specificity | 1 | 1996 | 2478 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2016 | 1081 | 0.020 |
Why?
|
Glucose | 1 | 2023 | 4398 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2016 | 867 | 0.020 |
Why?
|
Neurons | 2 | 2015 | 9340 | 0.020 |
Why?
|
Pregnancy | 1 | 2013 | 29144 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2016 | 1152 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2016 | 1184 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2016 | 14561 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2020 | 13991 | 0.020 |
Why?
|
Patient Admission | 1 | 2018 | 1380 | 0.020 |
Why?
|
Heart Arrest | 1 | 2000 | 1470 | 0.020 |
Why?
|
Adolescent | 2 | 2020 | 85779 | 0.020 |
Why?
|
Neuroglia | 1 | 2015 | 928 | 0.020 |
Why?
|
Electrocardiography | 2 | 2013 | 6442 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1655 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7323 | 0.020 |
Why?
|
Education, Medical | 1 | 2020 | 1722 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2864 | 0.020 |
Why?
|
Microglia | 1 | 2016 | 1267 | 0.020 |
Why?
|
Autopsy | 1 | 2012 | 1020 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2009 | 236 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2010 | 940 | 0.020 |
Why?
|
Insulin | 1 | 2022 | 6582 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2010 | 479 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1590 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2010 | 651 | 0.020 |
Why?
|
Mutation | 1 | 2011 | 29786 | 0.020 |
Why?
|
Brain Mapping | 1 | 2022 | 6670 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3444 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 7798 | 0.020 |
Why?
|
Motor Activity | 1 | 1996 | 2715 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2014 | 2019 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2971 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2010 | 1342 | 0.020 |
Why?
|
Pyrazoles | 1 | 2015 | 1972 | 0.020 |
Why?
|
Mesocricetus | 2 | 1995 | 252 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2005 | 234 | 0.020 |
Why?
|
Serotonin Antagonists | 2 | 1995 | 144 | 0.020 |
Why?
|
Medical Records | 1 | 2010 | 1413 | 0.020 |
Why?
|
Necrosis | 1 | 2008 | 1643 | 0.020 |
Why?
|
Survival Rate | 2 | 2013 | 12788 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.010 |
Why?
|
Gait | 1 | 2009 | 793 | 0.010 |
Why?
|
Gene Frequency | 1 | 2010 | 3587 | 0.010 |
Why?
|
Pyridines | 1 | 2015 | 2825 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2010 | 2026 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 1996 | 3966 | 0.010 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 4459 | 0.010 |
Why?
|
Databases as Topic | 1 | 2005 | 475 | 0.010 |
Why?
|
Headache | 1 | 2010 | 1226 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11486 | 0.010 |
Why?
|
Visual Perception | 1 | 2010 | 1420 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6539 | 0.010 |
Why?
|
Cricetinae | 2 | 1995 | 2475 | 0.010 |
Why?
|
Algorithms | 2 | 2015 | 13882 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3493 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2050 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 1107 | 0.010 |
Why?
|
Anemia | 1 | 2008 | 1503 | 0.010 |
Why?
|
Mice | 2 | 2016 | 81201 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2005 | 1026 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 41005 | 0.010 |
Why?
|
Basal Ganglia | 1 | 2000 | 546 | 0.010 |
Why?
|
GABA Agonists | 1 | 1996 | 111 | 0.010 |
Why?
|
Serotonin Agents | 1 | 1994 | 29 | 0.010 |
Why?
|
Pyridazines | 1 | 1996 | 202 | 0.010 |
Why?
|
Heart Rate | 1 | 2005 | 4092 | 0.010 |
Why?
|
Receptors, Serotonin | 1 | 1994 | 201 | 0.010 |
Why?
|
Child | 1 | 2020 | 77709 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1995 | 575 | 0.010 |
Why?
|
Cognition | 1 | 2009 | 6770 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2012 | 8038 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1994 | 1572 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14723 | 0.010 |
Why?
|
Light | 1 | 1995 | 1374 | 0.010 |
Why?
|
Sleep | 1 | 2002 | 4622 | 0.000 |
Why?
|
Protein Binding | 1 | 1996 | 9384 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1995 | 11366 | 0.000 |
Why?
|